
==== Front
Adv TherAdv TherAdvances in Therapy0741-238X1865-8652Springer Healthcare Cheshire 48110.1007/s12325-017-0481-3ErratumErratum to: Chronic Obstructive Pulmonary Disease Individualized Therapy: Tailored Approach to Symptom Management Singh Dave dsingh@meu.org.uk 1Miravitlles Marc 2Vogelmeier Claus 31 0000000121662407grid.5379.8University of Manchester, Manchester, UK 2 0000 0001 0675 8654grid.411083.fPneumology Department, Hospital Universitari Vall d’Hebron, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain 3 0000 0004 1936 9756grid.10253.35Department of Medicine, Pulmonary and Critical Care Medicine, Member of the German Center for Lung Research (DZL), University Medical Center Giessen and Marburg, Philipps-University Marburg, Marburg, Germany 31 1 2017 31 1 2017 2017 34 3 771 771 © The Author(s) 2017issue-copyright-statement© Springer Healthcare 2017
==== Body
Erratum to: Adv Ther DOI 10.1007/s12325-016-0459-6
The following text should have been included in the Acknowledgments section of this publication:

The content of this paper is based on a symposium held at the ERS meeting in Amsterdam in September 2015. AstraZeneca was invited to carry out a courtesy scientific accuracy review prior to peer review for any inaccuracy related to the contents of the meeting, but not influencing the content.


The online version of the original article can be found under doi:10.1007/s12325-016-0459-6.

Open Access
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
